Day 1 :
- Pediatric Nephrology
Session Introduction
Boris Ajdinovic
Military Medical Academy, Serbia
Title: Different guidelines for imaging in children with febrile urinary tract infections
Biography:
Abstract:
The best approach to imaging of a child with febrile urinary tract infection (UTI) is highly debatable. Renal ultrasound (US), a voiding cystourethrogram (VCUG) and renal dimercaptosuccinic acid (DMSA) scintigraphy are the most commonly used imaging methods. UTI are common in childhood, and most children recover without complications. Use of imaging to check for abnormalities or complications therefore needs to be targeted carefully. Because a renal US is noninvasive and may give supplemental information about a child’s risk for lower tract infections by showing bladder abnormalities, a renal US should be initially ordered study in children with UTI. In 2011. The American Academy of Pediatric (AAP) recommended that renal US be performed after first febrile UTI but that VCUG should be obtained only if there are renal abnormalities, or after second febrile UTI. Significant controversy surrounded this recommendation and many pediatric urologists disagreed with the APP guidelines (Logvinenko T. et al., 2015., Bush NC et al., 2015.). Obtaining a VCUG with first UTI in all male patients, females younger than 3 years, children clinically suspected of having pyelonephritis, and those with US abnormalities has been recommended (”bottom-up” approach).
- Renal Dialysis
Session Introduction
Chun-Jung Chien
NTU, Taiwan
Title: Investigate the Role of Thioredoxin Domain-containing Protein 5 (TXNDC5) in Peritoneal Dialysis-induced Peritoneal Fibrosis
Biography:
Chun-Jung Chien majors in veterinary medicine at NPUST, after obtaining her DVM license, she continues her study for a master degree in the conservation reproductive biology and regenerative medicine lab at the graduate institute of Veterinary Medicine at National Taiwan University. Her research focuses on investigating the mechanism of peritoneal dialysis-induced fibrosis and exploring novel therapeutic approaches for peritoneal fibrosis.
Abstract:
Statement of the Problem: Peritoneal dialysis (PD) is one of the kidney replacement therapies that maintain the lives of patients with kidney failure. Long-term PD will lead to peritoneal fibrosis (PF), which would cause functional and morphologic changes in the peritoneum and eventually result in ultrafiltration failure. Despite efforts being made, there is still no effective treatment that has been developed to alleviate PF. Recently, an endoplasmic reticulum protein, thioredoxin domain-containing protein 5 (TXNDC5), was identified as a novel mediator in the process of organ fibrosis in multiple organs. The purpose of this study is to explore a potential target to treat ultrafiltration failure by investigating the role of TXNDC5 in PF. Methodology & Theoretical Orientation: A 5-week methylglyoxal (MGO)-induced peritoneal fibrosis mouse model was established, and the peritoneal tissue was harvested to validate the expression of fibrosis-related proteins and protein expression of TXNDC5 via western blot and immunofluorescence staining. Findings: Histological and Masson’s trichrome staining showed MGO-induced significant peritoneum thickening when compared with PD fluid control group, indicating that the PF was successfully established (Fig. 1). Immunofluorescent staining confirmed that an increased TXNDC5 signal was present at the thickened parietal peritoneum. In addition, western blot results showed that both TXNDC5 and fibrogenesis-related signaling were upregulated in MGO-induced peritoneum (Fig. 2). Using Col-GFP transgenic mice (Col1a1-GFPTg), we showed mesothelial cells became Col-GFP positive on the peritoneal surface, indicated that mesothelial cells expressed collagen I secreting ability after MGO-induction, and likely play a role in the progression of MGO-induced peritoneal fibrosis (Fig. 3). Conclusion & Significance: TXNDC5 protein expression is increased after MGO induction and is positively correlated with fibrogenesis-related signaling. Therefore, targeting TXNDC5 could be a potential therapeutic approach against the development of PD-induced PF, which may prolong the service life of PD patients.
- Nephrology and Therapeutics
Session Introduction
Marie Angeline J. Mora
St. Luke’s Medical Center, Philippines
Title: The Effect of Finerenone in Reducing Disease Progression among patients with Chronic Kidney Disease: A systematic review and Meta-analysis
Biography:
Abstract:
- Chronic and End Stage Renal Diseases